Skip to main content
Signal8

Aubuchon Neil William

SEC insider (Form 3/4/5 filer). CIK 0002106781. Chief Commercial Officer at Viking Therapeutics, Inc. (VKTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2026. Located in SAN DIEGO, CA.

Companies Aubuchon Neil William has filed insider reports for

  • Viking Therapeutics, Inc. (VKTX): Officer, Chief Commercial Officer
Aubuchon Neil William profile photo

Aubuchon Neil William

CIK: 0002106781

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Viking Therapeutics, Inc. logo
VKTX

Viking Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Viking Therapeutics, Inc. logo
    VKTX

    Viking Therapeutics, Inc.

    Mar 10, 2026
    Purchase
    Direct
    4.5K shares at avg. $33.50$150K
  • Viking Therapeutics, Inc. logo
    VKTX

    Viking Therapeutics, Inc.

    Jan 12, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    180K shares-

1-2 of 2